# Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers

> **NCT02571738** · PHASE3 · TERMINATED · sponsor: **Osiris Therapeutics** · enrollment: 108 (actual)

## Conditions studied

- Chronic Diabetic Foot Ulcers

## Interventions

- **BIOLOGICAL:** CHAM
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT02571738
- **Lead sponsor:** Osiris Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10
- **Primary completion:** 2017-04
- **Final completion:** 2017-06
- **Target enrollment:** 108 (ACTUAL)
- **Why stopped:** Company's desire to allocate more research and development resources to other clinical programs. Decision not driven by any safety concerns.
- **Last updated:** 2017-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02571738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02571738, "Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02571738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*